Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001415889-25-011229
Filing Date
2025-04-23
Accepted
2025-04-23 18:10:03
Documents
2
Period of Report
2025-04-21

Document Format Files

Seq Description Document Type Size
1 form3-04232025_100400.html 3  
1 form3-04232025_100400.xml 3 8738
2 ex24-04232025_100400.htm EX-24 4804
  Complete submission text file 0001415889-25-011229.txt   15021
Mailing Address C/O EPIRUS BIOPHARMACEUTICALS, INC. 699 BOYLSTON STREET 8TH FLOOR BOSTON MA 02116
Business Address
Ticktin Robert (Reporting) CIK: 0001613482 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39539 | Film No.: 25862964

Mailing Address 400 ALEXANDER PARK DRIVE SUITE 301 PRINCETON NJ 08540
Business Address 400 ALEXANDER PARK DRIVE SUITE 301 PRINCETON NJ 08540 (609) 642-6670
PMV Pharmaceuticals, Inc. (Issuer) CIK: 0001699382 (see all company filings)

EIN.: 463218129 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)